Evaluation of the effects of hydroxyethyl starch (130/0.4) administration as a constant rate infusion on plasma colloid osmotic pressure in hypoabluminemic dogs.

Abstract

To evaluate the effects of 2 constant rate infusions of hydroxyethyl starch (HES) 130/0.4 on plasma colloid osmotic pressure (COP) in hypoalbuminemic dogs. Prospective, randomized clinical trial. A total of 24 client-owned dogs. Hypoalbuminemic euvolemic dogs (albumin<20g/L[<2g/dL]) with normal perfusion parameters requiring IV fluid therapy were enrolled. In addition to crystalloid, HES 130/0.4 was administered as a constant rate infusion over 24hours at 1mL/kg/h (group 1, n=15) or at 2mL/kg/h (group 2, n=9), in order to support plasma COP. Before infusion, a blood sample was collected to perform CBC, serum electrophoresis, and serologic tests for some infective diseases. Plasma COP, albumin concentration, PCV, and total plasma protein concentration were evaluated serially at baseline (T0) and then at 6, 12, and 24hours after the start of infusion, and a multilevel model was performed for these parameters to detect statistically significant differences between the 2 groups. Twenty-four dogs were included. No statistically significant differences in COP werefound between the 2 groups; however, a high level of variability has been identified within the single individual. Among the other laboratory analyses, PCV was significantly decreased in group 1 at T12 and T24 compared with T0 (P<0.001) and total plasma protein concentration was significantly increased in group 2 at T12 and T24 compared with T0 (P<0.008). No significant effect on plasma COP was found following infusion with HES 130/0.4 at doses of 1mL/kg/h and 2mL/kg/h for 24hours to hypoalbuminemic dogs. The administered concomitant dose of crystalloids, underlying disease, and small sample size were all potential confounding factors.